A Phase I Study of Quadrivalent HPV Recombinant Vaccine
Clinical trial NCT03085381 · COMPLETED
Trial details
- NCT number
- NCT03085381
- Sponsor
- Shanghai Bovax Biotechnology Co., Ltd.
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2016-12-01
- Primary completion
- 2017-10-01
- Enrollment
- 90
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.